×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the ...
Yahoo Finance
PRESS RELEASE THE PARIS COURT OF APPEAL CONFIRMS THE ACQUITTAL OF THE CEO OF AB SCIENCE, ALAIN MOUSSY, AND REDUCES THE AMOUNT OF THE...
3 days ago
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
Yahoo Finance
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development · Status of conditional...
1 month ago
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
GlobeNewswire
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS ... AB Science SA (Euronext -...
1 month ago
CHMP delays ruling on conditional EU approval of masitinib for ALS
ALS News Today
The European Medicines Agency committee's request for written answers to issues with the add-on ALS therapy could push an opinion to June.
3 months ago
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven ...
Yahoo Finance
PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS...
1 month ago
AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib ...
GlobeNewswire
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS ISSUED A NOTICE OF NON-COMPLIANCE-WITHDRAWAL (NON/w) FOR MASITINIB IN AMYOTROPHIC...
2 months ago
ALS oral therapy masitinib rejected by Health Canada
ALS News Today
AB Science has indicated it will ask Health Canada to reconsider its decision not to approve masitinib as an add-on treatment for ALS.
2 months ago
AB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral ...
GlobeNewswire
PRESS RELEASE AB SCIENCE ANNOUNCES AN UPDATE IN THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AT THE...
3 months ago
English learner advocates in California oppose ‘science of reading’ bill
EdSource
Two prominent organizations say the proposal would dismantle progress made to improve reading instruction for those students.
1 month ago
Health Canada agrees to reconsider request for masitinib approval
ALS News Today
AB Science was given the go-ahead to ask Health Canada to reconsider its decision against approving masitinib as an add-on treatment for...
4 weeks ago